US 12,343,222 B2
Device, system, and method for detection of medical device components and/or mating thereof
Noel Titus, New York, NY (US)
Assigned to Becton, Dickinson and Company, Franklin Lakes, NJ (US)
Filed by Becton, Dickinson and Company, Franklin Lakes, NJ (US)
Filed on Apr. 23, 2024, as Appl. No. 18/643,659.
Application 18/643,659 is a continuation of application No. 17/922,840, granted, now 11,992,374, previously published as PCT/US2021/031031, filed on May 6, 2021.
Claims priority of provisional application 63/021,496, filed on May 7, 2020.
Prior Publication US 2024/0268924 A1, Aug. 15, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. G06K 19/067 (2006.01); A61B 90/98 (2016.01)
CPC A61B 90/98 (2016.02) [G06K 19/0672 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A medical device assembly, comprising:
a first medical device component having at least one first resonant structure, the at least one first resonant structure having a first resonant frequency spectrum; and
a second medical device component having at least one second resonant structure, the at least one second resonant structure having a second resonant frequency spectrum different than the first resonant frequency spectrum,
wherein, upon mating of the first medical device component to the second medical device component, the at least one first resonant structure and the at least one second resonant structure combine to have a third resonant frequency spectrum, wherein the third resonant frequency spectrum is different than the first resonant frequency spectrum and the second resonant frequency spectrum,
wherein, upon interrogation of the first medical device component with an interrogation signal, at least one reflected signal associated with the at least one first resonant structure comprises at least one of an amplitude attenuation, a phase jump, or a frequency attenuation corresponding to the first resonant frequency spectrum,
wherein, upon interrogation of the second medical device component with the interrogation signal, at least one reflected signal associated with the at least one second resonant structure comprises at least one of an amplitude attenuation, a phase jump, or a frequency attenuation corresponding to the second resonant frequency spectrum, and
wherein, upon interrogation of the first medical device component mated with the second medical device component with the interrogation signal, at least one reflected signal associated with a combination of the at least one first resonant structure and the at least one second resonant structure comprises at least one of an amplitude attenuation, a phase jump, or a frequency attenuation corresponding to the third resonant frequency spectrum.